#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Inflammatory myofibroblastic tumour Sjogren's syndrome Hypophosphatasia Chronic myelomonocytic leukaemia Breast angiosarcoma Ovarian cancer Corneal neovascularisation Still's disease Acquired ATTR amyloidosis Liposarcoma recurrent SAPHO syndrome Waldenstrom's macroglobulinaemia recurrent Bulbospinal muscular atrophy congenital Extranodal marginal zone B-cell lymphoma (MALT type) Endometrial cancer More trials…

    Learn about Rare Diseases

    Hereditary motor and sensory neuropathy Ewing’s sarcoma metastatic – Trials in Disease MELAS syndrome – Treatment Waldenstrom’s macroglobulinaemia refractory – Life with Disease Idiopathic inflammatory myopathy Glomerulonephritis membranoproliferative – Treatment Optic glioma – Trials in Disease Haemophilia B with anti factor IX – Diagnostics Angiosarcoma metastatic Rhabdomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BENZYLPENICILLIN POTASSIUM AZD0292 Flutafuranol (18F) RIMIDUCID Ifosfamide FOSMANOGEPIX Buprenorphine VANADIUM OXIDE SULFATE Mirodenafil Dihydrochloride Flutemetamol (18F) Lacutamab Dipyridamole Cemiplimab FIBRIN Disitamab Vedotin Midostaurin Propranolol Hydrochloride Afatinib Topotecan Hydrochloride Setrusumab More therapies…

    Learn about Your Condition

    Hereditary ataxia Bronchostenosis Osteoporosis Glanzmann's disease Cardiac sarcoidosis Propionic acidaemia Bile duct cancer Streptococcal infection Medulloblastoma White matter lesion Alpha-1 antitrypsin deficiency Hyperthyroidism Dyskinesia Osteopenia Round cell liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Acetylsalicylic Acid for Preventing Preeclampsia in Pregnant Women

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pre-eclampsia
    Investigated Drugs:
    • Acetylsalicylic Acid
    Spain

  • Pembrolizumab for Patients with Localised dMMR Colon Cancer: Neoadjuvant and Organ-Sparing Treatment Study

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Pembrolizumab
    Denmark

  • Study to evaluate if colchicine reduces inflammation in patients with chronic coronary artery disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    • Coronary artery disease
    Investigated Drugs:
    • Colchicine
    • Placebo
    Denmark

  • Daridorexant for Insomnia in Patients with Major Depressive Disorder and Moderate to Severe Insomnia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Insomnia
    • Major depression
    Investigated Drugs:
    • Magnesium Stearate
    • Cellulose, Microcrystalline
    • Daridorexant
    Spain

  • AZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • AZD0120
    • Bortezomib
    • Carfilzomib
    France Germany Italy Norway Poland Spain

  • Angiotensin II in Children and Adolescents With Refractory Hypotension in Distributive Shock

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hypotension
    Investigated Drugs:
    • ANGIOTENSIN II
    • Sodium Chloride Solution 0.9%
    France Germany Italy Spain
Previous Page
1 … 713 714 715 716 717 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!